TY - JOUR
T1 - Reactivation of SARS-CoV-2 infection following recovery from COVID-19
AU - Chen, Zhihai
AU - Xie, Wen
AU - Ge, Ziruo
AU - Wang, Yajie
AU - Zhao, Hong
AU - Wang, Jingjing
AU - Xu, Yanli
AU - Zhang, Wei
AU - Song, Meihua
AU - Cui, Shuping
AU - Wang, Xiankun
AU - Pan, Calvin Q.
N1 - Publisher Copyright:
© 2021 The Authors
PY - 2021/5
Y1 - 2021/5
N2 - Introduction: Many individuals test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA after recovering from the coronavirus disease (COVID-19), but the incidence of reactivation is unknown. We, therefore, estimated the incidence of reactivation among individuals who had recovered from COVID-19 and determined its predictors. Methods: In this retrospective cohort study, patients with COVID-19 were followed up for at least 14 days after two consecutive negative SARS-CoV-2 polymerase chain reaction test results obtained ≥24 h apart, and the frequency of SARS-CoV-2 reactivation was assessed. Results: Of the 109 patients, 29 (27%) experienced reactivation, and seven (24%) of these were symptomatic. The mean period for the real-time PCR tests for SARS-CoV-2 from negative to positive results was 17 days. Compared with patients without reactivation, those with reactivation were significantly younger and more likely to have a lymphocyte count of <1500/μL (odds ratio [OR]: 0.34, 95% confidence interval [CI]: 0.12–0.94) and two or fewer symptoms (OR: 0.20, 95% CI: 0.07–0.55) during the initial episode. Conclusion: Risk-stratified surveillance should be conducted among patients who have recovered from COVID-19.
AB - Introduction: Many individuals test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA after recovering from the coronavirus disease (COVID-19), but the incidence of reactivation is unknown. We, therefore, estimated the incidence of reactivation among individuals who had recovered from COVID-19 and determined its predictors. Methods: In this retrospective cohort study, patients with COVID-19 were followed up for at least 14 days after two consecutive negative SARS-CoV-2 polymerase chain reaction test results obtained ≥24 h apart, and the frequency of SARS-CoV-2 reactivation was assessed. Results: Of the 109 patients, 29 (27%) experienced reactivation, and seven (24%) of these were symptomatic. The mean period for the real-time PCR tests for SARS-CoV-2 from negative to positive results was 17 days. Compared with patients without reactivation, those with reactivation were significantly younger and more likely to have a lymphocyte count of <1500/μL (odds ratio [OR]: 0.34, 95% confidence interval [CI]: 0.12–0.94) and two or fewer symptoms (OR: 0.20, 95% CI: 0.07–0.55) during the initial episode. Conclusion: Risk-stratified surveillance should be conducted among patients who have recovered from COVID-19.
KW - COVID-19 relapse
KW - Coronavirus reactivation
KW - Persistent coronavirus infection
KW - Real-Time reverse transcription-polymerase chain reaction
KW - Recurrent SARS-CoV-2 infection
UR - http://www.scopus.com/inward/record.url?scp=85103968115&partnerID=8YFLogxK
U2 - 10.1016/j.jiph.2021.02.002
DO - 10.1016/j.jiph.2021.02.002
M3 - Article
C2 - 33848891
AN - SCOPUS:85103968115
SN - 1876-0341
VL - 14
SP - 620
EP - 627
JO - Journal of Infection and Public Health
JF - Journal of Infection and Public Health
IS - 5
ER -